79 related articles for article (PubMed ID: 20818975)
1. Antiproliferative activity of N6-isopentenyladenosine on MCF-7 breast cancer cells: cell cycle analysis and DNA-binding study.
Rajabi M; Signorelli P; Gorincioi E; Ghidoni R; Santaniello E
DNA Cell Biol; 2010 Nov; 29(11):687-91. PubMed ID: 20818975
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative activity of N(6)-isopentenyladenosine on HCT-15 colon carcinoma cell line.
Rajabi M; Mehrzad J; Gorincioi E; Santaniello E
Nucleic Acid Ther; 2011 Oct; 21(5):355-8. PubMed ID: 22004416
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells.
Laezza C; Malfitano AM; Di Matola T; Ricchi P; Bifulco M
Mol Carcinog; 2010 Oct; 49(10):892-901. PubMed ID: 20672320
[TBL] [Abstract][Full Text] [Related]
4. N6-Isopentenyladenosine promoted HeLa cell apoptosis through inhibitions of AKT and transforming growth factor β-activated kinase 1 activation.
Li M; Qi Y; Wei J; Lu L; Zhao X; Zhou L
Tumour Biol; 2017 Mar; 39(3):1010428317695966. PubMed ID: 28345459
[TBL] [Abstract][Full Text] [Related]
5. N6-isopentenyladenosine and its analogue N6-benzyladenosine induce cell cycle arrest and apoptosis in bladder carcinoma T24 cells.
Castiglioni S; Casati S; Ottria R; Ciuffreda P; Maier JA
Anticancer Agents Med Chem; 2013 May; 13(4):672-8. PubMed ID: 23094912
[TBL] [Abstract][Full Text] [Related]
6. N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1.
Laezza C; Caruso MG; Gentile T; Notarnicola M; Malfitano AM; Di Matola T; Messa C; Gazzerro P; Bifulco M
Int J Cancer; 2009 Mar; 124(6):1322-9. PubMed ID: 19058178
[TBL] [Abstract][Full Text] [Related]
7. Novel isopentenyladenosine analogues: synthesis, characterization, and evaluation of antiproliferative activity on bladder carcinoma cells.
Ottria R; Casati S; Maier JA; Mariotti M; Ciuffreda P
Nucleosides Nucleotides Nucleic Acids; 2009 Aug; 28(8):736-51. PubMed ID: 20183613
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative activity and cell cycle analysis of 2-(3,5-dihydroxyphenyl)-6-hydroxybenzothiazole on MCF-7 breast and HCT-15 colon cancer cell lines.
Rajabi M; Minutolo F; Bertini S; Macchia M; Ghidoni R
DNA Cell Biol; 2011 Aug; 30(8):617-21. PubMed ID: 21438664
[TBL] [Abstract][Full Text] [Related]
9. N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity.
Pagano C; Coppola L; Navarra G; Avilia G; Savarese B; Torelli G; Bruzzaniti S; Piemonte E; Galgani M; Laezza C; Bifulco M
FEBS Open Bio; 2024 May; 14(5):843-854. PubMed ID: 38514913
[TBL] [Abstract][Full Text] [Related]
10. N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice.
Ciaglia E; Pisanti S; Picardi P; Laezza C; Sosa S; Tubaro A; Vitale M; Gazzerro P; Malfitano AM; Bifulco M
Pharmacol Res; 2014 Nov; 89():1-10. PubMed ID: 25063359
[TBL] [Abstract][Full Text] [Related]
11. N6-isopentenyladenosine: a potential therapeutic agent for a variety of epithelial cancers.
Spinola M; Colombo F; Falvella FS; Dragani TA
Int J Cancer; 2007 Jun; 120(12):2744-8. PubMed ID: 17304507
[TBL] [Abstract][Full Text] [Related]
12. N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux.
Ranieri R; Ciaglia E; Amodio G; Picardi P; Proto MC; Gazzerro P; Laezza C; Remondelli P; Bifulco M; Pisanti S
Cell Death Differ; 2018 Feb; 25(2):353-367. PubMed ID: 29027991
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics and analogues of the antitumour agent N6-isopentenyladenosine.
Colombo F; Falvella FS; De Cecco L; Tortoreto M; Pratesi G; Ciuffreda P; Ottria R; Santaniello E; Cicatiello L; Weisz A; Dragani TA
Int J Cancer; 2009 May; 124(9):2179-85. PubMed ID: 19123479
[TBL] [Abstract][Full Text] [Related]
14. Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug.
Bifulco M; Malfitano AM; Proto MC; Santoro A; Caruso MG; Laezza C
Anticancer Agents Med Chem; 2008 Feb; 8(2):200-4. PubMed ID: 18288922
[TBL] [Abstract][Full Text] [Related]
15. 2-(3,5-Dihydroxyphenyl)-6-hydroxybenzothiazole arrests cell growth and cell cycle and induces apoptosis in breast cancer cell lines.
Rajabi M
DNA Cell Biol; 2012 Mar; 31(3):388-91. PubMed ID: 21838530
[TBL] [Abstract][Full Text] [Related]
16. Activation of caspase-like proteases and induction of apoptosis by isopentenyladenosine in tobacco BY-2 cells.
Mlejnek P; Procházka S
Planta; 2002 May; 215(1):158-66. PubMed ID: 12012253
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation.
Pisanti S; Picardi P; Ciaglia E; Margarucci L; Ronca R; Giacomini A; Malfitano AM; Casapullo A; Laezza C; Gazzerro P; Bifulco M
FASEB J; 2014 Mar; 28(3):1132-44. PubMed ID: 24265487
[TBL] [Abstract][Full Text] [Related]
18. Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction.
Zhang M; Chiu LC; Cheung PC; Ooi VE
Oncol Rep; 2006 Mar; 15(3):637-43. PubMed ID: 16465424
[TBL] [Abstract][Full Text] [Related]
19. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
[TBL] [Abstract][Full Text] [Related]
20. N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation.
Ciaglia E; Pisanti S; Picardi P; Laezza C; Malfitano AM; D'Alessandro A; Gazzerro P; Vitale M; Carbone E; Bifulco M
J Leukoc Biol; 2013 Dec; 94(6):1207-19. PubMed ID: 23847096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
